Yueyang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China; Clinical Research Institute of Integrative Medicine, Shanghai Academy of Traditional Chinese Medicine, Shanghai, China.
Yueyang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Biomed Pharmacother. 2019 Mar;111:325-330. doi: 10.1016/j.biopha.2018.12.086. Epub 2018 Dec 24.
Scutellaria baicalensis Georgi is an extensively used medicinal herb for the treatment of hypertension in traditional Chinese medicine. Baicalin is the most abundant flavone compound present in Scutellaria baicalensis Georgi and endothelium-dependent vascular activities of baicalin have been suggested. However, the pharmacological implications and mechanisms of baicalin under hypertensive conditions remain to be investigated. The current study examined the blood pressure-lowering effect of baicalin in a spontaneously hypertensive rat (SHR) model. Moreover, vascular activities and mechanisms of baicalin were investigated under hypertensive conditions. The results demonstrate that baicalin treatment lowers the blood pressure in SHRs in vivo. Ex vivo vascular reactivity assay reveals that baicalin relaxes phenylephrine (PE)-constricted SHR aortas in an endothelium-independent manner. Baicalin attenuates Angiotensin II (Ang II) or potassium chloride (KCl)-induced vasoconstriction in SHR aortas as well. Baicalin also relaxes SHR aortas in the presence of different Ca channel blockers such as nifedipine and SKF96365 in response to PE-induced constriction. Most importantly, ATP-sensitive potassium channel (K) blockade partially abrogated the vasorelaxant effect of baicalin. In summary, the current study demonstrates for the first time that intracellular Ca regulation in vascular smooth muscle is mechanistically implicated in the vasorelaxant effect of baicalin under hypertensive conditions. Furthermore, activated K channels are in part required for the vasorelaxant effect of baicalin under hypertensive conditions. Thus, the work here sheds novel pharmacological and mechanistic insights into the blood pressure-lowering effect of baicalin, which may help better understand the therapeutic application of Scutellaria baicalensis Georgi in the treatment of hypertension.
黄芩是一种广泛应用于传统中药治疗高血压的药用植物。黄芩苷是黄芩中最丰富的黄酮类化合物,已表明其具有内皮依赖性血管活性。然而,在高血压条件下,黄芩苷的药理作用和机制仍有待研究。本研究在自发性高血压大鼠(SHR)模型中考察了黄芩苷的降压作用。此外,还研究了高血压条件下黄芩苷的血管活性和机制。结果表明,黄芩苷治疗可降低 SHR 体内的血压。离体血管反应性测定表明,黄芩苷以非内皮依赖性方式舒张苯肾上腺素(PE)收缩的 SHR 主动脉。黄芩苷还可减轻血管紧张素 II(Ang II)或氯化钾(KCl)诱导的 SHR 主动脉收缩。黄芩苷还可在不同的钙通道阻滞剂(如硝苯地平和 SKF96365)存在下,通过减轻 PE 诱导的收缩来舒张 SHR 主动脉。最重要的是,三磷酸腺苷敏感性钾通道(K)阻断部分阻断了黄芩苷的血管舒张作用。总之,本研究首次表明,血管平滑肌细胞内 Ca 调节在高血压条件下黄芩苷的血管舒张作用的机制中起重要作用。此外,在高血压条件下,激活的 K 通道部分参与了黄芩苷的血管舒张作用。因此,这里的工作为黄芩苷的降压作用提供了新的药理学和机制见解,这可能有助于更好地理解黄芩在治疗高血压中的治疗应用。